A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Clinical trial NCT05858749 · COMPLETED
Trial details
- NCT number
- NCT05858749
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-20
- Primary completion
- 2022-11-30
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.